Comparison of the effects of two different doses of magnesium with placebo on severity of pain of menstrual and amount of menstrual bleeding

Comparison of the effects of two different doses of magnesium (150? 300 mg) with placebo on severity of primary dysmenorrhea and amount of menstrual bleeding in female students (18-34 years old)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015080319743N2

Enrollment

Registered

2016-01-22

Start date

2016-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorreha. primary dysmenorrhea

Interventions

Intervention 1: Taking Tablets containing 150 mg Magnesium once a day from 15th day of menstrual cycle to complete relief of pain for two months. Intervention 2: Control group: Taking Tablets containi

Treatment - Drugs

Placebo

Taking Tablets containing 150 mg Magnesium once a day from 15th day of menstrual cycle to complete relief of pain for two months.

Control group: Taking Tablets containing placebo once a day from 15th day of menstrual cycle to complete relief of pain for two months.

Intervention 2: Taking Tablets containing 300 mg Magnesium once a day from 15th day of menstrual cycle to complete relief of pain for two months.

Eligibility

Sex/Gender

Female

Age

18 Years to 34 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Single students aged 18-34 years residing in dormitory, having primary dysmenorrhea, regular and painful menstruation in previous 1 year with pain score equal or more than 5 according to visual analogue scale. Exclusion criteria: Known serious diseases like epilepsy, severe digestive disorders, cardiovascular, renal diseases, pelvic inflammatory diseases, consumption of oral contraceptive pills in previous 6 months or desire to take them during study and allergy to NSAIDs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mean severity of menstrual pain. Timepoint: Before and two months after intervention. Method of measurement: Visual Analogue Scale (VAS).;Amount of menstrual bleeding. Timepoint: Before and two months after intervention. Method of measurement: Higham Chart.	—

Secondary

Measure	Time frame
Need to take additional pain relief drug for dysmenorrhea. Timepoint: Before and two months after intervention. Method of measurement: Number of analgesics used.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalimeh Nezamivand-Chegini

Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences

Nezamivandsalime@yahoo.com+98 61 3336 7543

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026